Transition Bio
Based out of Cambridge, MA, Transition Bio is a drug discovery and diagnostics platform provider with a focus on the discovery, analysis, and modulation of biological condensates.
Last updated on
About Transition Bio
Founded
2020Employees
11-50Funding / Mkt. Cap
$50MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsLocation
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (62)
